Wall Street analyst estimates for Ralph Lauren Corporation (RL): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Ralph Lauren Corporation is a prominent international entity primarily involved in the creation, marketing, and distribution of premium lifestyle goods across North America, Europe, Asia, and other global regions. The company's diverse product range includes: Apparel: A comprehensive selection of clothing for men, women, and children.
Consensus price target
$456.67 (+16 % vs price $392.87)
between $425.00 and $511.00 · 10 targets published in the last quarter
Closing price, Oct 30
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2027E | $8.7B | $8.6B – $9.0B | $18.88 | 9 |
| 2028E | $9.1B | $8.9B – $9.8B | $20.88 | 9 |
Fiscal year ending in March · figures in USD · consensus as of October 29, 2026
Analyst Consensus
| Strong Buy | 1 |
| Buy | 31 |
| Hold | 13 |
| Sell | 3 |
| Strong Sell | 0 |
| Total analysts | 48 |
| Avg rating (−2 sell to +2 buy) | 0.62 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-05 | $4.22 | ||
| 2026-08-06 | $4.59 | $4.32 | +6.2% |
| 2026-05-21 | $2.80 | $2.55 | +9.8% |
| 2026-02-05 | $6.22 | $5.80 | +7.2% |
| 2025-11-06 | $3.79 | $3.45 | +9.9% |
| 2025-08-07 | $3.77 | $3.51 | +7.4% |
| 2025-05-22 | $2.27 | $2.04 | +11.3% |
| 2025-02-06 | $4.82 | $4.46 | +8.1% |
Valuation Ratios
| P/E Ratio | 24.77 |
| Price / Book | 8.44 |
| EV / EBITDA | 16.55 |
| Dividend Yield | 1.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.65B | $6.18B | $6.31B | $6.16B | $4.40B | $6.22B | $6.44B | $6.63B | $7.08B | $8.11B |
| Cost of Revenue | $3.00B | $2.43B | $2.43B | $2.51B | $1.54B | $2.07B | $2.28B | $2.20B | $2.23B | $2.45B |
| Gross Profit | $3.65B | $3.75B | $3.89B | $3.65B | $2.86B | $4.15B | $4.17B | $4.43B | $4.85B | $5.67B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $3.20B | $3.12B | $3.20B | $3.27B | $2.65B | $3.31B | $3.41B | $3.60B | $3.86B | $4.37B |
| Operating Expenses | $3.74B | $3.25B | $3.32B | $3.34B | $2.90B | $3.35B | $3.46B | $3.68B | $3.92B | $4.49B |
| Operating Income | -$92.3M | $498.2M | $561.8M | $317.0M | -$43.6M | $798.4M | $704.2M | $756.4M | $932.1M | $1.18B |
| EBITDA | $215.0M | $802.6M | $884.5M | $613.5M | $221.3M | $1.04B | $952.8M | $1.05B | $1.21B | $1.41B |
| Interest Expense | $12.4M | $18.2M | $20.7M | $17.6M | $48.5M | $54.0M | $40.4M | $42.2M | $44.1M | $54.2M |
| Pre-tax Income | -$104.9M | $489.2M | $582.5M | $326.4M | -$74.8M | $754.6M | $691.9M | $777.4M | $950.7M | $1.18B |
| Income Tax | -$5.6M | $326.4M | $151.6M | -$57.9M | $46.3M | $154.5M | $169.2M | $131.1M | $207.8M | $236.6M |
| Net Income | -$99.3M | $162.8M | $430.9M | $384.3M | -$121.1M | $600.1M | $522.7M | $646.3M | $742.9M | $941.1M |
| EPS | $-1.20 | $1.99 | $5.35 | $5.07 | $-1.65 | $8.22 | $7.72 | $9.91 | $11.86 | $15.42 |
| EPS (Diluted) | $-1.20 | $1.97 | $5.27 | $4.98 | $-1.65 | $8.08 | $7.58 | $9.72 | $11.61 | $15.11 |
| Shares Outstanding (Diluted) | 82.7 M | 82.5 M | 81.7 M | 77.2 M | 73.5 M | 74.3 M | 69.0 M | 66.5 M | 64.0 M | 62.3 M |
Price
| Price | $392.87 (closing price, October 30, 2026) |
| Market Cap | $23.4B |
| Exchange | NYSE |
| Country | US |
Related companies: TPR · PVH · ZGN · CPRI
Explore sector: Consumer Cyclical · Apparel - Manufacturers
More sections of RL: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks